A detailed history of Pinnacle West Asset Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Pinnacle West Asset Management, Inc. holds 4,100 shares of NVS stock, worth $472,648. This represents 0.34% of its overall portfolio holdings.

Number of Shares
4,100
Previous 4,100 -0.0%
Holding current value
$472,648
Previous $397,000 9.82%
% of portfolio
0.34%
Previous 0.32%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$95.27 - $108.47 $1,905 - $2,169
20 Added 0.49%
4,100 $397,000
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $16,608 - $18,277
180 Added 4.62%
4,080 $412,000
Q3 2023

Nov 07, 2023

BUY
$94.73 - $105.13 $59,206 - $65,706
625 Added 19.08%
3,900 $397,000
Q2 2023

Aug 15, 2023

SELL
$92.52 - $104.91 $11,565 - $13,113
-125 Reduced 3.68%
3,275 $330,000
Q1 2023

May 10, 2023

BUY
$80.03 - $92.81 $272,102 - $315,554
3,400 New
3,400 $313,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $248B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Pinnacle West Asset Management, Inc. Portfolio

Follow Pinnacle West Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle West Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle West Asset Management, Inc. with notifications on news.